Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.) metabolome obtained in Full Scan

ABSTRACT: Data acquired by LC-MS in full scan mode (MS1) in a five point dilution series of methanolic extracts (methanol:water) for actinomycetes BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.).

INSTRUMENT(S): Impact II QToF Bruker Daltonics

ORGANISM(S): Streptomyces Sp. (ncbitaxon:1931) Micromonospora Sp. (ncbitaxon:1876) Actinomadura Sp. (ncbitaxon:1989)

SUBMITTER: Ricardo Roberto da Silva

PROVIDER: MSV000095042 | MassIVE | Fri Jun 14 12:32:00 BST 2024

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.) metabolome obtained in LC-MS/MS with a scheduled precursor list (SPL)

Project description:Data obtained by LC-MS/MS of methanolic extracts (methanol:water) for the actinomycetes BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.), where the precursor ions were guided by a scheduled precursor list (SPL).

2024-06-24 | MSV000095129 | MassIVE

Streptomyces sp. M7 LC-MS - Streptomyces sp. M7 has demonstrated ability to remove lindane from culture media and soils

Project description:Streptomyces sp. M7 has demonstrated ability to remove lindane from culture media and soils. In this study, we used MS-based label-free quantitative proteomic to understand lindane degradation and its metabolic context in Streptomyces sp. M7. We identified the proteins involved in the up-stream degradation pathway. Our results demonstrated that mineralization of lindane is feasible since proteins from an unusual down-stream degradation pathway were also identified. Degradative steps were supported by an active catabolism that supplied energy and reducing equivalents in the form of NADPH. This is the first study in which degradation steps of an organochlorine compound and metabolic context are elucidate in a biotechnological genus as Streptomyces. These results serve as basement to study other degradative actinobacteria and to improve the degradation processes of Streptomyces sp. M7.

2018-08-10 | PXD010607 | Pride

Examination of polyester-polyurethane degradation by Streptomyces sp. PU10

Project description:This study aimed to investigate the variations in the protein composition of Streptomyces sp. PU10 when cultivated with either Impranil (polyestere-polyurethane) or glucose as the carbon source. We analyzed both the intracellular and extracellular protein fractions to gain insights into the intricate processes involving PU degradation, intermediate metabolic pathways in PU degradation, and the connection between primary and secondary metabolism within Streptomyces sp. PU10.

2024-03-29 | PXD047534 | Pride

GNPS - BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.) metabolome obtained in LC-MS/MS in DDA mode

Project description:Data acquired by LC-MS/MS DDA mode of methanolic extracts (methanol:water) for actinomycetes BRA006 (Micromonospora sp.), BRA010 (Streptomyces sp.) and BRA177 (Actinomadura sp.)

2024-06-14 | MSV000095044 | GNPS

Streptomyces sp. MB42 proteomics response to catechin, dopamine, phenylephrine

Project description:Streptomyces sp. MB42 produces antimicrobial compound under the pressence of specific compounds. This experiment is to see which gene cluster upregulated during the treatment of target compound.

2022-02-04 | PXD029669 | Pride

Proteomic study of Streptomyces sp. MC1 exposed to Cr(VI) and phenanthrene

Project description:The aim of this work was to understand the response of Streptomyces sp. MC1 when exposed to Cr(VI) and phenantrene.

2020-11-25 | PXD018877 | Pride

Streptomyces sp. CB0028 and Escovopsis sp. CBACRO424

Project description:Fungus-growing ants microbial interaction of Streptomyces sp. and Escovopsis sp. through molecular networking and MALDI imaging

2018-11-03 | MSV000083097 | MassIVE

Total protein of S. aureus treated and untreated with Streptomyces sp. GKU 223

Project description:This study is aimed to isolate marine actinomycetes from sediments from Andaman and the Gulf of Thailand. All 101 marine actinomycetes were screened for anti-biofilm activity. Streptomyces sp. GKU223 showed significantly inhibited biofilm formation of S. aureus. The evaluation of supernatants of anti-biofilm activity produced by Streptomyces sp. GKU223 has been performed. Since the interaction between marine actinomycetes and biofilm forming bacteria has never been investigated, proteomic analysis has been used to identify whole cell proteins involved in anti–biofilm activity. Understanding the interaction at molecular level will lead to sustainably use for anti-biofilm producing marine actinomycetes in pharmaceutical and medicinal applications in the future.

2018-08-20 | PXD010815 | JPOST Repository

Streptomyces sp. ATCC 14903

Project description:Analysis of culture extracts from Streptomyces sp. ATCC 14903 and comparison to actinonin commercial standard

2017-08-16 | MSV000081445 | MassIVE

Analysis of Escherichia coli treated and untreated with Streptomyces sp. GKU 257-1

Project description:This study is aimed to isolate marine actinomycetes from sediments from Andaman and the Gulf of Thailand. All 101 marine actinomycetes were screened for anti-biofilm activity. Streptomyces sp. GKU 257-1 showed significantly inhibited biofilm formation of E. coli. The evaluation of supernatants of anti-biofilm activity produced by Streptomyces sp. GKU 257-1 has been performed. Since the interaction between marine actinomycetes and biofilm forming bacteria has never been investigated, proteomic analysis has been used to identify whole cell proteins involved in anti–biofilm activity. Understanding the interaction at molecular level will lead to sustainably use for anti-biofilm producing marine actinomycetes in pharmaceutical and medicinal applications in the future.

2019-09-07 | PXD011027 | JPOST Repository

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data